First Batch of TroClose 1200™ 2.0 Products Successfully Enter International Medical Market

In February 2026, the first batch of TroClose 1200™ 2.0 products departed from Chengdu Economic Development Zone, crossing oceans to destinations including the United States, Israel, Singapore, and Japan, marking the official entry into top global medical institutions, such as Allegheny Health Network (AHN) in the United States.

This successful overseas shipment not only fully validates Lujian Technology’s comprehensive strength in medical device R&D transformation and industrialization but also marks a key step forward in the company’s commercialization process. From technology introduction and FDA-compliant production to entering global high-level healthcare networks, Lujian Technology is steadily advancing its international expansion with a clear strategic path, continuously bringing China’s innovative medical solutions to the global stage.